Logo

Agencourt Bioscience

May 20, 2004
Premium

Agencourt Bioscience has launched an expanded SNP-discovery service for pre-validated sequencing assays of kinases.

The company has also said it has licensed the new service to the Dana-Farber Cancer Institute, which will use it to sequence assays developed by cancer researchers Matthew Meyerson, and William Sellers. For this deal, Agencourt will offer both pre-validated sequencing assays and a kinase-discovery program in which polymorphisms in more than 92 kinases have previously been mapped. Financial terms of the licensing agreement were not released.

Filed under

Diagnostics
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.